• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC DE COSTA RICA S.R.L. POLARX; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC DE COSTA RICA S.R.L. POLARX; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Lot Number 0032675795
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Nerve Damage (1979)
Event Date 12/01/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that during a cryo pulmonary vein isolation (pvi) procedure to treat atrial fibrillation a polarx catheter was selected for use.The first freeze of the right superior pulmonary vein (rspv) was stopped due to warm temperatures.The second freeze was double stopped when phrenic nerve activity started to gradually decrease.Phrenic nerve activity was monitored via pacing from the orion mapping catheter in the superior vena cave (svc).Pacing of the phrenic nerve tried periodically for the next hour, but no stimulation was ever recovered.The left superior pulmonary vein (lspv) had been ablated and a radiofrequency ablation device was used to isolate the right inferior pulmonary vein (ripv).The procedure was competed with no patient complications.The device is not expected to be returned for analysis due to disposal.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that during a cryo pulmonary vein isolation (pvi) procedure to treat atrial fibrillation a polarx catheter was selected for use.The first freeze of the right superior pulmonary vein (rspv) was stopped due to warm temperatures.The second freeze was double stopped when phrenic nerve activity started to gradually decrease.Phrenic nerve activity was monitored via pacing from the orion mapping catheter in the superior vena cave (svc).Pacing of the phrenic nerve tried periodically for the next hour, but no stimulation was ever recovered.The left superior pulmonary vein (lspv) had been ablated and a radiofrequency ablation device was used to isolate the right inferior pulmonary vein (ripv).The procedure was competed with no further patient complications.The device is not expected to be returned for analysis due to disposal.It was further reported that the patient was kept at the hospital over the weekend after the procedure.The patient was clearly out of breath due to the complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLARX
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC DE COSTA RICA S.R.L.
302 parkway
global park, la aurora
heredia
CS 
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18274908
MDR Text Key329839304
Report Number2124215-2023-68918
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number0032675795
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2023
Initial Date FDA Received12/06/2023
Supplement Dates Manufacturer Received01/04/2024
Supplement Dates FDA Received01/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/19/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-